Newbury Pharmaceuticals AB (NEWBRY) Revenue

0 Followers

Newbury Pharmaceuticals AB Revenue

Newbury Pharmaceuticals AB had a revenue of 12.43M in the quarter ending Feb 28, 2025, with 90.18%. This bring the company's revenue in the last twelve months to 41.48M, Decreased 28.90%. In the fiscal year ending Aug 31, 2024, Newbury Pharmaceuticals AB had annual revenue of 36.83M with 258.75% growth.

Revenue (ttm)

41.48M

Revenue Growth

―

P/S Ratio

1.86

Revenue/Employee

kr5,261,286

Employees

Market Cap

kr68.40M

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Aug 31, 2024	36.83M	26.56M	+258.75%
Aug 31, 2023	10.27M	4.75M	+86.11%
Aug 31, 2022	5.52M	2.69M	+94.98%
Aug 31, 2021	2.83M	―	―